产品封面图
文献支持

M-07e细胞

收藏
  • ¥1980
  • EK-Bioscience已认证
  • CCC-Y1327
  • 2025年07月14日
    avatar
    品牌商
    12钻石会员
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    M-07e、M-07e、M-07e细胞、M-07e细胞、M-07e人巨细胞白血病细胞

    Cell line name M-07e

    Synonyms M-07E; M-O7e; M07-e; M07e; Mo7e; MO7e; M07E; MO7E

    Accession CVCL_2106

    Resource Identification Initiative To cite this cell line use: M-07e (RRID:CVCL_2106)

    Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: LL-100 blood cancer cell line panel.

    Population: Caucasian.

    Doubling time: 46 +- 12 hours (PubMed=9096695); ~40 hours (DSMZ=ACC-104).

    Omics: Deep exome analysis.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.

    Sequence variations

    Gene fusion; HGNC; 31677; ANO7 + HGNC; 17887; DHDH; Name(s)=ANO7-DHDH (PubMed=31160637).

    Gene fusion; HGNC; 1537; CBFA2T3 + HGNC; 29450; GLIS2; Name(s)=CBFA2T3-GLIS2, ETO2-GLIS2 (PubMed=28109323).

    Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (DepMap=ACH-000602).

    HLA typing Source: DSMZCellDive=ACC-104

    Class I

    HLA-A A*24:02:01,66:01:01

    HLA-B B*13:02:01,49:01:01

    HLA-C C*06:02:01;07:01:01

    Genome ancestry Source: PubMed=30894373

     

    Origin % genome

    African 8.96

    Native American 0

    East Asian, North 0.92

    East Asian, South 0

    South Asian 3.01

    European, North 45.47

    European, South 41.63

    Disease Childhood acute megakaryoblastic leukemia (NCIt: C7972)

    Acute megakaryoblastic leukemia (ORDO: Orphanet_518)

    Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)

    Hierarchy Parent: CVCL_D630 (M-07)

    Children:

    CVCL_RM07 (M-07e/TPO)

    Sex of cell Female

    Age at sampling 6M

    Category Cancer cell line

    STR profile Source(s): CCRID=1101HUM-PUMC000112; DSMZ=ACC-104

     

    Markers:

    Amelogenin X

    CSF1PO 9,10

    D2S1338 19,25

    D3S1358 16,19

    D5S818 11

    D7S820 11

    D8S1179 13 (DSMZ=ACC-104)

    13,16 (CCRID=1101HUM-PUMC000112)

    D13S317 10,11

    D16S539 11

    D18S51 15,20

    D19S433 14,15

    D21S11 30,32.2

    FGA 18,22

    Penta D 9

    Penta E 12,14

    TH01 6,8

    TPOX 8

    vWA 16,18

     

    Run an STR similarity search on this cell line

    PubMed=2273055; DOI=10.1002/jcp.1041450310

    Avanzi G.C., Brizzi M.F., Giannotti J., Brennan A., Yang Y.-C., Pegoraro L., Clark S.C.

    M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3.

    J. Cell. Physiol. 145:458-464(1990)

     

    PubMed=9096695; DOI=10.1038/sj.leu.2400621

    Drexler H.G., Zaborski M., Quentmeier H.

    Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.

    Leukemia 11:541-551(1997)

     

    DOI=10.1016/B978-0-12-221970-2.50457-5

    Drexler H.G.

    The leukemia-lymphoma cell line factsbook.

    (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

     

    PubMed=11414198; DOI=10.1007/s004320000207

    Lahm H., Andre S., Hoeflich A., Fischer J.R., Sordat B., Kaltner H., Wolf E., Gabius H.-J.

    Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.

    J. Cancer Res. Clin. Oncol. 127:375-386(2001)

     

    PubMed=16408098; DOI=10.1038/sj.leu.2404081

    Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.

    JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.

    Leukemia 20:471-476(2006)

     

    PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027

    Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

    The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

    Nature 483:603-607(2012)

     

    PubMed=28109323; DOI=10.1186/s13045-017-0396-0; PMCID=PMC5251306

    Masetti R., Bertuccio S.N., Astolfi A., Chiarini F., Lonetti A., Indio V., De Luca M., Bandini J., Serravalle S., Franzoni M., Pigazzi M., Martelli A.M., Basso G., Locatelli F., Pession A.

    Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.

    J. Hematol. Oncol. 10:26.1-26.5(2017)

     

    PubMed=30285677; DOI=10.1186/s12885-018-4840-5; PMCID=PMC6167786

    Tan K.-T., Ding L.-W., Sun Q.-Y., Lao Z.-T., Chien W., Ren X., Xiao J.-F., Loh X.-Y., Xu L., Lill M., Mayakonda A., Lin D.-C., Yang H.H., Koeffler H.P.

    Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

    BMC Cancer 18:940.1-940.13(2018)

     

    PubMed=30629668; DOI=10.1371/journal.pone.0210404; PMCID=PMC6328144

    Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.

    Screening human cell lines for viral infections applying RNA-Seq data analysis.

    PLoS ONE 14:E0210404-E0210404(2019)

     

    PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675

    Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

    An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

    Cancer Res. 79:1263-1273(2019)

     

    PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103

    Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. 3rd, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.

    Next-generation characterization of the Cancer Cell Line Encyclopedia.

    Nature 569:503-508(2019)

     

    PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646

    Quentmeier H., Pommerenke C., Dirks W.G., Eberth S., Koeppel M., MacLeod R.A.F., Nagel S., Steube K.G., Uphoff C.C., Drexler H.G.

    The LL-100 panel: 100 cell lines for blood cancer studies.

    Sci. Rep. 9:8218-8218(2019)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由上海酶研生物科技有限公司提供;

    *发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.

    相关实验
    • 缪勒氏细胞 Müller cell

      脊椎动物网膜的神经胶质细胞。其上端达外界膜,下端达内界膜,是贯穿网膜全层的大型细胞。在发生学上是来源于室管膜细胞(ependymal cell)。作为网膜的支持组织,对神经的保护、营养、代谢等方面可能起着重要作用。另外,也有人认为和网膜电位的发生有关。  

    • Stem Cell Rep:高绍荣团队揭示 Mettl14 以不依赖于 m⁶A 的方式驱动衰老相关分泌表型促进体细胞重编程

      N6-甲基腺苷(m6A)修饰与人类疾病息息相关,它通过影响包括细胞周期、细胞命运决定和细胞稳态等 1 生命进程的多个方面来调节人类疾病。m6A 修饰的建立由 Mettl3-Mettl14 甲基转移酶复合物(MTC)催化 2。通过 Yamanaka 因子(Oct4、Sox2、Klf4 和 c-Myc,称为 OSKM)将体细胞重编程为诱导性多能干细胞(iPSCs)3,为研究细胞命运转变的分子机制提供了一个很好的研究系统。之前研究表明 Mettl3 的过量达可以增加 m6A 的水平,促进体细胞重编

    • Mol Cell:浙大王青青团队等合作揭示乳酸化调控 RNA m⁶A 修饰促进肿瘤浸润髓系细胞的免疫抑制功能

      转移酶 METTL3 介导的肿瘤浸润髓系细胞(tumor-infiltrating myeloid cells, TIMs)的 N6-甲基腺嘌呤(N6-methyladenosine,m6A)修饰,促进 TIMs 的免疫抑制功能,介导肿瘤的免疫逃逸。 肿瘤浸润髓系细胞主要包括肿瘤相关巨噬细胞 (tumor-associated macrophages, TAMs)、髓系来源抑制性细胞 (myeloid-derived suppressor cells, MDSCs)、肿瘤相关中性粒细胞 (tumor

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥600
    上海信裕生物科技有限公司
    2025年07月12日询价
    ¥680
    上海联迈生物工程有限公司
    2025年07月13日询价
    ¥600
    上海再康生物科技有限公司
    2025年11月21日询价
    ¥1800
    博辉生物科技(广州)有限公司
    2025年09月24日询价
    ¥1800
    上海酶研生物科技有限公司
    2026年01月08日询价
    文献支持
    M-07e细胞
    ¥1980